Vizgen | $48,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026) Certified by Founder
Lodge
Incredo
start up
Israel
- Petach-Tikva
- 25/05/2023
- Series C
- $30,000,000
Incredo LTD. (Formerly DouxMatok)
We are on a mission to make the world a happier and healthier place. With the introduction of Incredo® Sugar, we can empower both delicious taste and improved nutrition, all while curbing the overconsumption of sugar.
- Industry Food and Beverage Services
- Website https://www.douxmatok.com/
- LinkedIn https://www.linkedin.com/company/incredo1/
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)
Lemon Slice | $10,500,000 | (Jan 7, 2026)